AB-FUBINACA

1. 2026-10-19issueIssued emergency
2. 2026-10-19issueIssued info_card
3. 2026-09-07srcIn vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA
4. 2026-09-07srcIdentification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry
5. 2026-09-07srcExtraordinary long detection window of a synthetic cannabinoid metabolite in human urine - Potential impact on therapeutic decisions
6. 2026-09-07srcLog D7.4 and plasma protein binding of synthetic cannabinoid receptor agonists
7. 2026-09-07srcDifferential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists
8. 2026-09-07srcNew cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products
9. 2026-09-07srcThe 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities
10. 2026-09-07srcDifferentiation of AB-FUBINACA and its five positional isomers using liquid chromatography-electrospray ionization-linear ion trap mass spectrometry and triple quadrupole mass spectrometry
11. 2026-09-07srcIn vivo assessment of the nephrotoxic effects of the synthetic cannabinoid AB-FUBINACA
12. 2026-09-07srcSynthetic Cannabinoid AB-FUBINACA Negatively Impacted the Male Fertility and Induced Testicular Toxicity
13. 2026-09-07srcProfound hypotension and bradycardia in the setting of synthetic cannabinoid intoxication - A case series
14. 2026-09-07srcAcute intoxication caused by three common synthetic cannabinoids: The experience of a large, urban, tertiary care hospital
15. 2026-09-07srcHuman Laboratory Studies on Cannabinoids and Psychosis
16. 2026-09-07srcThe short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice
17. 2026-09-07srcMolecular signaling of synthetic cannabinoids: Comparison of CB1 receptor and TRPV1 channel activation
18. 2026-09-07srcNew psychoactive substances - 96 cases of deaths related to their use based on forensic toxicological practice.
19. 2026-09-07srcDelineating the molecular mechanisms of hippocampal neurotoxicity induced by chronic administration of synthetic cannabinoid AB-FUBINACA in mice
20. 2026-09-07srcPharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
21. 2026-09-07src"Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
22. 2026-09-07srcSupraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations
23. 2026-09-07srcDetection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings
24. 2026-09-07srcCYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48
25. 2026-09-07srcSynthetic Cannabinoids are Genotoxic in Cultured Human Lymphocytes
26. 2026-09-07srcEnantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples
27. 2026-09-07srcA Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists
28. 2026-09-07srcSpice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis
29. 2026-09-07srcUNODC Laboratory and Scientific Service: AB-FUBINACA Substance Details
30. 2026-09-07srcSchedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I
31. 2026-09-04issueIssued emergency
32. 2026-09-04issueIssued info_card
33. 2026-09-04issueIssued notice
34. 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
35. 2026-06-04publicationPublication — backfill
36. 2026-05-11revisionRevision 1
37. 2026-05-11absenceSearched ClinicalTrials.gov for "AB-FUBINACA synthetic cannabinoid" — no results
38. 2026-05-11genGeneration — pipeline-v5 · with 2 morepipeline-v5
39. 2026-05-11rungeneration run

The same entries, as forms: six forms.